Search
for
Sort by
Research 31–60 of 100
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Beyond acne: Current aspects of sebaceous gland biology and function
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Hormonal treatment of acne vulgaris: an update
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Evaluation of hair loss
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Treatment of hyperandrogenism in women
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Polycystic ovary syndrome: An update on diagnosis and management
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Acquired scalp alopecia. Part II: A review
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Novel agents for the treatment of alopecia
- Desideratum dermatologicum--cause and control of premenstrual acne flare
- Androgenetic Alopecia
- Disorders of hair
- Caring for women with polycystic ovary syndrome
- An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 5-alpha-dihydrotestosterone in human serum and plasma
- The endocrinology of baldness
- Urinary steroids in women with androgenic alopecia
- Androgens and Antiandrogens
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome